(Q37266709)

English

Importance of CA125 normalization during neoadjuvant chemotherapy followed by planned delayed surgical debulking in patients with epithelial ovarian cancer

scientific article published on August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Importance of CA125 normalization during neoadjuvant chemotherapy followed by planned delayed surgical debulking in patients with epithelial ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

neoadjuvant chemotherapy

1 reference

based on heuristic

inferred from title

author name string

Tien Le

1

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Wylam Faught

2

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Laura Hopkins

3

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Michael Fung-Kee-Fung

4

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

publication date

1 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Journal of Obstetrics and Gynaecology Canada

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

665-670

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of early changes in the serum CA-125 antigen level on overall survival in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

CA125 regression during neoadjuvant chemotherapy as an independent prognostic factor for survival in patients with advanced ovarian serous adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932914-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1701-2163(16)32914-0

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37266709&oldid=1698788922"